Study on the effective dose of alfentanil compounded with propofol for gastroscopy anesthesia

Status

Active, not recruiting

Phases

Phase 4

Study type

Observational

Source

ChiCTR

Registry ID

ChiCTR2200063245

Enrollment

Unknown

Registered

2022-09-02

Start date

2022-09-01

Completion date

Unknown

Last updated

2023-04-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Gastritis

Interventions

Intervention group:Propofol combined with alfentanil

Eligibility

Sex/Gender

All

Age

18 Years to 60 Years

Inclusion criteria

Inclusion criteria: 1. Patients volunteering for painless gastroscopy; 2. Aged 18-60 years; 3. ASA I-II patients.

Exclusion criteria

Exclusion criteria: 1. Contraindications to the use of drugs in the project; 2. Patients with neurological or psychiatric diseases; 3. Patients with a history of drug abuse.

Design outcomes

Primary

Measure	Time frame
Half effective dose;	—

Countries

China

Contacts

Public ContactHuang Jinping

The Seventh Affiliated Hospital of Southern Medical University

976225757@qq.com+86 13539770857

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026